RIBOBODY
LIVE

Serial Number

98623781

Owner

Ribo Therapeutics Inc.

Attorney

Christina M. Licursi

Filing Date

Jun 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RIBOBODY Trademark

Serial Number: 98623781

RIBOBODY is a trademark filed by Ribo Therapeutics Inc. on June 28, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Ribo Therapeutics Inc.

450 W 42nd Street, Unit 20N
New York, NY 10036

Entity Type: 03

Trademark Details

Filing Date

June 28, 2024

Registration Date

Not Registered

Published for Opposition

October 7, 2025

Goods & Services

Pharmaceutical, therapeutic pharmaceuticals, and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, RNA-based therapeutic pharmaceuticals and therapeutic agents for the treatment of a variety of human and animal diseases and disorders; medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of human and animal diseases and disorders

Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; custom RNA targeting and assay development for the treatment of a variety of human and animal diseases and disorders in the field of biotechnology; pharmaceutical drug development related to proteins, ribosomes, DNA and RNA

Chemicals for use in therapeutic product development and manufacturing processes in the medical field; Biological and chemical agents, namely, chemical preparations for scientific and research use; chemicals for use in biotherapeutics in the biochemical and chemical industries and excluding medical and veterinary purpose; biological preparations for use in industry and science; chemical agents, namely, chemical preparations for analyses in laboratories, other than for medical or veterinary purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2026 EXRA
SOU EXTENSION 1 GRANTED
May 26, 2026 EX1G
SOU EXTENSION 1 FILED
May 26, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
May 26, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 2, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 28, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 28, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 28, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2025 NWOS
NEW APPLICATION ENTERED
Jun 28, 2024 NWAP